Jimini Health introduced Sage, a clinically supervised AI therapist assistant, as part of its patient-facing behavioral health platform. Launched by Jimini Health, Sage provides 24/7 support between therapy sessions, featuring AI-driven conversations that clinicians can review and manage. The company announced a $17 million seed financing round to scale the technology to more care settings and national provider organizations.
The funding attracted investors including M13, Town Hall Ventures, LionBird, Zetta Venture Partners and OneMind and builds on Jimini Health’s 2024 debut. Sage includes guided exercises, conversational check-ins and handoffs to clinicians when needed, with all interactions visible to care teams to maintain clinical oversight. By extending access to continuous, supervised support, Sage aims to reduce gaps between appointments, improve adherence to therapeutic exercises and integrate AI as a monitored extension of clinical care.
Clinically Supervised AI Assistants
Jimini Health Launches Sage AI Therapist Assistant
Trend Themes
1. Clinically Supervised AI Assistants - A rise in monitored AI therapist assistants that maintain clinician oversight presents opportunities to scale supervised, high-frequency patient interactions while preserving care quality.
2. Continuous AI-enabled Care - Extending support between appointments through 24/7 AI touchpoints offers potential to reduce treatment gaps and improve adherence to therapeutic regimens across larger populations.
3. AI-clinician Collaborative Workflows - Shared visibility of AI-patient interactions introduces possibilities for streamlined handoffs and prioritized clinician interventions based on AI-flagged risk signals.
Industry Implications
1. Behavioral Health - Integration of supervised AI assistants into therapy pathways could expand access to evidence-based behavioral interventions and augment clinician capacity.
2. Healthtech Platforms - Platform providers that incorporate clinician-reviewed AI features may capture new markets by offering compliant, continuously engaged care ecosystems.
3. Insurance and Payers - Payer models that recognize supervised AI touchpoints as billable or quality-improving services could shift reimbursement toward hybrid human-AI care delivery.